SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-512858"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-512858" > Renoprotective effe...

  • Giontella, AliceLund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups (författare)

Renoprotective effects of genetically proxied fibroblast growth factor 21 : Mendelian randomization, proteome-wide and metabolome-wide association study

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • Elsevier BV,2023
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-512858
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-512858URI
  • https://doi.org/10.1016/j.metabol.2023.155616DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:153685542URI
  • https://lup.lub.lu.se/record/f147a8f4-f005-497c-a782-06ec2421b482URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background: Fibroblast growth factor 21 (FGF21) has demonstrated efficacy for reducing liver fat and reversing non-alcoholic steatohepatitis in phase 2 clinical trials. It is also postulated to have anti-fibrotic effects and therefore may be amenable to repurposing for the prevention and treatment of chronic kidney disease (CKD).Methods: We leverage a missense genetic variant, rs739320 in the FGF21 gene, that associates with magnetic resonance imaging-derived liver fat as a clinically validated and biologically plausible instrumental variable for studying the effects of FGF21 analogs. Performing Mendelian randomization, we ascertain associations between instrumented FGF21 and kidney phenotypes, cardiometabolic disease risk factors, as well as the circulating proteome (Somalogic, 4907 aptamers) and metabolome (Nightingale platform, 249 metabolites).Results: We report consistent renoprotective associations of genetically proxied FGF21 effect, including higher glomerular filtration rates (p = 1.9 x 10(-4)), higher urinary sodium excretion (p = 5.1 x 10(-11)), and lower urine albumin-creatinine ratio (p = 3.6 x 10(-5)). These favorable effects translated to lower CKD risk (odds ratio per rs739320 C-allele, 0.96; 95%CI, 0.94-0.98; p = 3.2 x 10(-4)). Genetically proxied FGF21 effect was also associated with lower fasting insulin, waist-to-hip ratio, blood pressure (systolic and diastolic BP, p < 1.0 x 10(- 07)) and blood lipid (low-density lipoprotein cholesterol, triglycerides and apolipoprotein B, p < 6.5 x 10(-24)) profiles. The latter associations are replicated in our metabolome-wide association study. Proteomic perturbations associated with genetically predicted FGF21 effect were consistent with fibrosis reduction.Conclusion: This study highlights the pleiotropic effects of genetically proxied FGF21 and supports a re-purposing opportunity for the treatment and prevention of kidney disease specifically. Further work is required to

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Zagkos, LoukasImperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.,Imperial College London (författare)
  • Geybels, MilanNovo Nord, Data Sci, Soborg, Denmark.,Novo Nordisk A/S (författare)
  • Larsson, Susanna C.Uppsala University,Karolinska Institute,Karolinska Institutet,Uppsala universitet,Medicinsk epidemiologi,Karolinska Inst, Inst Environm Med, Unit Cardiovasc & Nutr Epidemiol, Stockholm, Sweden.(Swepub:uu)susla720 (författare)
  • Tzoulaki, IoannaImperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.;Acad Athens, Biomed Res Fdn, Div Syst Biol, Athens, Greece.,Imperial College London,Academy of Athens (författare)
  • Mantzoros, Christos S.Harvard Med Sch, Boston VA Healthcare Syst, Dept Med, Boston, MA USA.;Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA.,Harvard Medical School (författare)
  • Andersen, BirgitteNovo Nord, Global Drug Dev, Copenhagen, Denmark.,Novo Nordisk A/S (författare)
  • Gill, DipenderImperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.;Novo Nord, Chief Sci Advisor Off, Res & Early Dev, Copenhagen, Denmark.,Novo Nordisk A/S,Imperial College London (författare)
  • Cronje, Helene T.Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Copenhagen, Denmark.;Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Oster Farimagsgade 5, DK-1353 Copenhagen, Denmark.,University of Copenhagen (författare)
  • Kardiovaskulär forskning - hypertoniForskargrupper vid Lunds universitet (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Metabolism: Elsevier BV1450026-04951532-8600

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy